TL;DR: Astraea is a Y Combinator Spring 2026 startup AI Operating System for Clinical Development, currently active with a team of 2.
AI Operating System for Clinical Development
Last verified:
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Yes. Astraea was funded by Y Combinator in the Spring 2026 batch. AI Operating System for Clinical Development
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, rev…
Astraea was part of Y Combinator's Spring 2026 batch.
Astraea has a team of 2 people according to Y Combinator's directory.
Astraea is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…